• Barzon, L., Pacenti, M., Franchin, E., Lavezzo, E., Trevisan, M., Sgarabotto, D., Palù, G., 2016. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro surveillance. 21, 30316.

  • Bluemling, G.R., Mao, S., Natchus, M.G., Painter, W., Mulangu, S., Lockwood, M., De La Rosa, A., Brasel, T., Comer, J.E., Freiberg, A.N., Kolykhalov, A.A., Painter, G.R., 2022. The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N(4)-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection. Antiviral research. 209, 105453.

  • Cugola, F.R., Fernandes, I.R., Russo, F.B., Freitas, B.C., Dias, J.L., Guimarães, K.P., Benazzato, C., Almeida, N., Pignatari, G.C., Romero, S., Polonio, C.M., Cunha, I., Freitas, C.L., Brandão, W.N., Rossato, C., Andrade, D.G., Faria Dde, P., Garcez, A.T., Buchpigel, C.A., Braconi, C.T., Mendes, E., Sall, A.A., Zanotto, P.M., Peron, J.P., Muotri, A.R., Beltrão-Braga, P.C., 2016. The Brazilian Zika virus strain causes birth defects in experimental models. Nature. 534, 267-271.

  • Faye, O., Freire, C.C., Iamarino, A., Faye, O., de Oliveira, J.V., Diallo, M., Zanotto, P.M., Sall, A.A., 2014. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS neglected tropical diseases. 8, e2636.

  • Lessler, J., Chaisson, L.H., Kucirka, L.M., Bi, Q., Grantz, K., Salje, H., Carcelen, A.C., Ott, C.T., Sheffield, J.S., Ferguson, N.M., Cummings, D.A., Metcalf, C.J., Rodriguez-Barraquer, I., 2016. Assessing the global threat from Zika virus. Science. 353, aaf8160.

  • Li, J.Q., Deng, C.L., Gu, D., Li, X., Shi, L., He, J., Zhang, Q.Y., Zhang, B., Ye, H.Q., 2018. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus. Antiviral research. 150, 148-154.

  • Li, Y., Liu, M., Yan, Y., Wang, Z., Dai, Q., Yang, X., Guo, X., Li, W., Chen, X., Cao, R., Zhong, W., 2022. Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo. Viruses. 14, 1142.

  • Nicastri, E., Castilletti, C., Liuzzi, G., Iannetta, M., Capobianchi, M.R., Ippolito, G., 2016. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro surveillance. 21, 30314.

  • Nie, Y., Hui, L., Guo, M., Yang, W., Huang, R., Chen, J., Wen, X., Zhao, M., Wu, Y., 2021. Rearrangement of Actin Cytoskeleton by Zika Virus Infection Facilitates Blood-Testis Barrier Hyperpermeability. Virologica Sinica 36, 692-705.

  • Pacheco, O., Beltrán, M., Nelson, C.A., Valencia, D., Tolosa, N., Farr, S.L., Padilla, A.V., Tong, V.T., Cuevas, E.L., Espinosa-Bode, A., Pardo, L., Rico, A., Reefhuis, J., González, M., Mercado, M., Chaparro, P., Martínez Duran, M., Rao, C.Y., Muñoz, M.M., Powers, A.M., Cuéllar, C., Helfand, R., Huguett, C., Jamieson, D.J., Honein, M.A., Ospina Martínez, M.L., 2020. Zika Virus Disease in Colombia-Preliminary Report. The New England journal of medicine. 383, e44.

  • Rosenke, K., Okumura, A., Lewis, M.C., Feldmann, F., Meade-White, K., Bohler, W.F., Griffin, A., Rosenke, R., Shaia, C., Jarvis, M.A., Feldmann, H., 2022. Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. JCI insight. 7, e160108.

  • Sargent, K., Mollard, J., Henley, S.F., Bollasina, M.A., 2022. Predicting Transmission Suitability of Mosquito-Borne Diseases under Climate Change to Underpin Decision Making. International journal of environmental research and public health. 19, 13656.

  • Toots, M., Yoon, J.J., Cox, R.M., Hart, M., Sticher, Z.M., Makhsous, N., Plesker, R., Barrena, A.H., Reddy, P.G., Mitchell, D.G., Shean, R.C., Bluemling, G.R., Kolykhalov, A.A., Greninger, A.L., Natchus, M.G., Painter, G.R., Plemper, R.K., 2019. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Science translational medicine. 11, eaax5866.

  • Voordouw, B., Rockx, B., Jaenisch, T., Fraaij, P., Mayaud, P., Vossen, A., Koopmans, M., 2019. Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays. Clinical microbiology reviews. 33, e00130-18.

  • Wang, H., Li, Z., Niu, J., Xu, Y., Ma, L., Lu, A., Wang, X., Qian, Z., Huang, Z., Jin, X., Leng, Q., Wang, J., Zhong, J., Sun, B., Meng, G., 2018. Antiviral effects of ferric ammonium citrate. Cell discovery 4, 14.

  • Wang, Q., Cao, R., Li, L., Liu, J., Yang, J., Li, W., Yan, L., Wang, Y., Yan, Y., Li, J., Deng, F., Zhou, Y., Wang, M., Zhong, W., Hu, Z., 2022a. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean-Congo hemorrhagic fever virus. Antiviral research. 199, 105273.

  • Wang, Z., Yan, Y., Dai, Q., Xu, Y., Yin, J., Li, W., Li, Y., Yang, X., Guo, X., Liu, M., Chen, X., Cao, R., Zhong, W., 2022b. Azelnidipine Exhibits In Vitro and In Vivo Antiviral Effects against Flavivirus Infections by Targeting the Viral RdRp. Viruses. 14, 1228.

  • WHO, 2022. Zika epidemiology update-February 2022. https://www.who.int/publications/m/item/zika-epidemiology-update-february-2022 (Accessed 21 April 2023)

  • Wikan, N., Smith, D.R., 2016. Zika virus:history of a newly emerging arbovirus. The Lancet. Infectious diseases. 16, e119-e126.

  • Yan, Y., Yang, J., Xiao, D., Yin, J., Song, M., Xu, Y., Zhao, L., Dai, Q., Li, Y., Wang, C., Wang, Z., Ren, X., Yang, X., Ni, J., Liu, M., Guo, X., Li, W., Chen, X., Liu, Z., Cao, R., Zhong, W., 2022. Nafamostat mesylate as a broad-spectrum candidate for the treatment of flavivirus infections by targeting envelope proteins. Antiviral research. 202, 105325.

  • Yang, J., Yan, Y., Dai, Q., Yin, J., Zhao, L., Li, Y., Li, W., Zhong, W., Cao, R., Li, S., 2022. Tilorone confers robust in vitro and in vivo antiviral effects against severe fever with thrombocytopenia syndrome virus. Virologica Sinica. 37, 145-148.